Any current/future new fundraising through debt or equity?

The transcript does not mention any current or planned fundraising through debt or equity. Raj Gupta notes ongoing capex plans of about INR 600 crores annually across businesses but does not specify new debt or equity issuance. Interest expenses are discussed, including capitalizations, but no indication of fresh debt raising. No explicit comments on equity fundraising or capital raising activities. Overall, the focus is on internal capital allocation and operational improvements rather than external fundraising.

Any current/future capex/capital investment/strategic investment?

PCBL is completing acquisition of 116 acres at Naidupeta, Andhra Pradesh, for a Greenfield Carbon Black project focusing on Rubber Black and Performance Chemicals. Capex to start post environmental clearance this year. Planning a new Specialty Black line (20,000 MTPA) at Mundra, expected ready in next 3-4 quarters, increasing Specialty Black capacity to 132,000 MTPA. Capex ongoing for 1,000 MTPA Specialty Black capacity (superconductive grade) in Palej, completion expected by end of FY '26. Annual average capex of around INR 600 crores planned across Carbon Black, Aquapharm, and Nanovace

Future growth expectations in sales/revenue/volumes?

PCBL expects continuous growth in sales volume, with a focus on increasing exports, especially to international markets like the US, Europe, and Asia, which offer significant headroom for expansion. Specialty Carbon Black volumes have grown from less than 1% in 2015 to over 10% now; this share is expected to keep ramping up over the next few years. New capacity additions, including brownfield expansions in Tamil Nadu and a planned greenfield plant in Andhra Pradesh, will increase total capacity to about 170,000 tons, supporting volume growth over the next 2-3 years. The company aims to i

Future growth expectations in earnings/operating earnings/profits/EPS?

PCBL expects growth from increased capacity utilization in Carbon Black, moving toward full capacity (~97%) this year. Specialty Carbon Black segment aims for 25-30% higher realizations versus normal grades, supporting margin expansion. New Specialty Carbon Black lines are planned, with full plant commissioning expected in 2.5-3 years, improving EBITDA. Product portfolio expansion and efficiency improvements are anticipated to drive INR4-5 per kg EBITDA increase over 4-5 years. Aquapharm business is projected to improve significantly over the next 3-4 quarters, with current investments targeti

Current/ Expected Orderbook/ Pending Orders?

The transcript does not provide specific details about the current or expected order book or pending orders for PCBL Chemical Limited. Raj Gupta mentions it is "a little early" to see concrete benefits or changes in orders from larger export clients following the Orion plant closure announcement. The Orion plant closure by end of the year might lead to some benefit, but tangible order impacts are expected only over time. There is no direct mention of pending or confirmed order quantities or values. The company expects volume growth and capacity utilization improvements in Specialty Carbon Blac

IN US

Sale is live|00:00:00left today

PCBL Chemical LtdQ2 FY25Chemicals & Petrochemicals

PCBL Chemical Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹317P/E: 50.3Market Cap: ₹10.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→PCBL expects continuous growth in sales volume, with a focus on increasing exports, especially to international markets like the US, Europe, and Asia, which offer significant headroom for expansion.
→Specialty Carbon Black volumes have grown from less than 1% in 2015 to over 10% now; this share is expected to keep ramping up over the next few years.
→New capacity additions, including brownfield expansions in Tamil Nadu and a planned greenfield plant in Andhra Pradesh, will increase total capacity to about 170,000 tons, supporting volume growth over the next 2-3 years.
→The company aims to improve product mix with Specialty and Performance Carbon Black, which have 25-30% and 7-10% higher realizations respectively compared to normal Carbon Black.
→Aquapharm business is anticipated to grow steadily, with current investments expected to yield better returns in 3-4 years.
→Overall, management is optimistic about growth despite current macroeconomic challenges and expects improving profitability from operating leverage and portfolio expansion.

Margin guidance

Category 3

→PCBL expects growth from increased capacity utilization in Carbon Black, moving toward full capacity (~97%) this year.
→Specialty Carbon Black segment aims for 25-30% higher realizations versus normal grades, supporting margin expansion.
→New Specialty Carbon Black lines are planned, with full plant commissioning expected in 2.5-3 years, improving EBITDA.
→Product portfolio expansion and efficiency improvements are anticipated to drive INR4-5 per kg EBITDA increase over 4-5 years.
→Aquapharm business is projected to improve significantly over the next 3-4 quarters, with current investments targeting ~17-18% ROCE in 3-4 years.
→Plant closures in Europe/North America may open export opportunities, boosting international sales beyond the current 41% mix.
→Operating leverage benefits expected in subsequent quarters should improve margins and profitability.
→Overall, PCBL is optimistic about earnings growth, driven by capacity expansions, premium products, export growth, and efficiency gains.

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript does not mention any current or planned fundraising through debt or equity.
→Raj Gupta notes ongoing capex plans of about INR 600 crores annually across businesses but does not specify new debt or equity issuance.
→Interest expenses are discussed, including capitalizations, but no indication of fresh debt raising.
→No explicit comments on equity fundraising or capital raising activities.
→Overall, the focus is on internal capital allocation and operational improvements rather than external fundraising.

Order book

→The transcript does not provide specific details about the current or expected order book or pending orders for PCBL Chemical Limited.
→Raj Gupta mentions it is "a little early" to see concrete benefits or changes in orders from larger export clients following the Orion plant closure announcement.
→The Orion plant closure by end of the year might lead to some benefit, but tangible order impacts are expected only over time.
→There is no direct mention of pending or confirmed order quantities or values.
→The company expects volume growth and capacity utilization improvements in Specialty Carbon Black over the next 1-2 years, implying positive order momentum, but no exact figures are given.
→Exports have been growing, indicating an increasing international order presence, but specific order book numbers aren't disclosed.

Capex plans

Yes

→PCBL is completing acquisition of 116 acres at Naidupeta, Andhra Pradesh, for a Greenfield Carbon Black project focusing on Rubber Black and Performance Chemicals. Capex to start post environmental clearance this year.
→Planning a new Specialty Black line (20,000 MTPA) at Mundra, expected ready in next 3-4 quarters, increasing Specialty Black capacity to 132,000 MTPA.
→Capex ongoing for 1,000 MTPA Specialty Black capacity (superconductive grade) in Palej, completion expected by end of FY '26.
→Annual average capex of around INR 600 crores planned across Carbon Black, Aquapharm, and Nanovace businesses.
→Residual capex commitments: Nanovace INR 200-250 crores; Aquapharm INR 100-125 crores annually; rest for Carbon Black.
→Small new line in Tamil Nadu to commission in 2-3 weeks.
→Construction on new Carbon Black greenfield line estimated at 18 months post approvals, expected fully done in around 2.5-3 years.

How does PCBL Chemical Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1PCBL Chemical Ltd

Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like PCBL Chemical Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio